货号 (SKU)

包装规格

是否现货

价格

数量

Ab175476-100μg

100μg

现货

Ab175476-1mg

1mg

现货

Ab175476-5mg

5mg

现货

Ab175476-10mg

10mg

期货

基本信息

产品名称	Bococizumab (anti-PCSK9), 9 型枯草蛋白酶/kexin 抗体
别名	伯考赛珠单抗 \| 博柯西单抗（抗 PCSK9）
英文别名	Convertase subtilisin/kexin type 9 preproprotein antibody \| FH3 antibody \| HCHOLA3 antibody \| Hypercholesterolemia autosomal dominant 3 antibody \| LDLCQ1 antibody \| NARC 1 antibody \| NARC-1 antibody \| NARC1 antibody \| Neural apoptosis regulated convertase
规格或纯度	无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属	人(Human)
特异性	PCSK9
种属反应性	人(Human),小鼠(Mouse),食蟹猴(Cynomolgus monkey)
偶联	Unconjugated
作用类型	抑制剂
作用机制	9 型枯草蛋白酶/kexin 抗体

产品属性

克隆类型	重组抗体
Format	Whole IgG
亚型	Human IgG2
轻链亚型	kappa
SDS-PAGE	26.6 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 180.0kDa, under non-reducing conditions.
纯化方法	Protein A purified
纯度	>95%
物理外观	Liquid
储存缓冲液	Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂	No
浓度	见COA
储存温度	-80℃储存,避免反复冻融
运输条件	超低温冰袋运输
稳定性与储存	在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息	1407495-02-6
分子类型	抗体

图片

SEC: Bococizumab (anti-PCSK9) (Ab175476)

Bococizumab (anti-PCSK9) (Ab175476) - SEC
The purity of Bococizumab (anti-PCSK9) (Ab175476) is more than 95% verified by HPLC.

ELISA: Bococizumab (anti-PCSK9) (Ab175476)

Bococizumab (anti-PCSK9) (Ab175476) - ELISA
Immobilized hu-PCSK9-chis at 2 μg/mL can bind Bococizumab (anti-PCSK9) (Ab175476) with the EC₅₀ of 6.92 ng/mL.

关联靶点（人）

PCSK9 Tclin 前蛋白转化酶枯草溶菌素/kexin 9 型(Proprotein convertase subtilisin/kexin type 9) (0 活性数据)

点击查看靶蛋白信息： PCSK9

活性类型	活性值-log(M)	作用机制	期刊	参考文献(PubMed IDs)

PCSK9 Tclin Subtilisin/kexin type 9 (362 活性数据)

点击查看靶蛋白信息： PCSK9

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

作用机制

作用机制	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	参考文献

安全和危险性（GHS）

SDS英文版

技术规格说明书

技术规格说明书

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):

输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到6个结果

批号(Lot Number)	证书类型	日期	货号
ZJ24F1013218	分析证书	24-11-01	Ab175476
ZJ24F1013217	分析证书	24-11-01	Ab175476
ZJ24F1013216	分析证书	24-11-01	Ab175476
ZJ24F0303753	分析证书	24-03-29	Ab175476
ZJ24F0303752	分析证书	24-03-29	Ab175476
ZJ24F0303751	分析证书	24-03-29	Ab175476

可替换产品

参考文献

1. Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D et al.. (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.. Nat Genet, 34 (2): (154-6). [PMID:12730697] [10.1021/op500134e]
2. Xu S, Luo S, Zhu Z, Xu J. (2019) Small molecules as inhibitors of PCSK9: Current status and future challenges.. Eur J Med Chem, 162 (13): (212-233). [PMID:30448414] [10.1021/op500134e]
3. Pettersen D, Fjellström O.. (2018) Small molecule modulators of PCSK9 - A literature and patent overview.. Bioorg Med Chem Lett, 28 (7): (1155-1160). [PMID:29519739] [10.1016/j.bmcl.2018.02.046]
4. Alleyne C,Amin RP,Bhatt B,Bianchi E,Blain JC,Boyer N,Branca D,Embrey MW,Ha SN,Jette K,Johns DG,Kerekes AD,Koeplinger KA,LaPlaca D,Li N,Murphy B,Orth P,Ricardo A,Salowe S,Seyb K,Shahripour A,Stringer JR,Sun Y,Tracy R,Wu C,Xiong Y,Youm H,Zokian HJ,Tucker TJ. (2020) Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design.. J Med Chem, 63 (22): (13796-13824). [PMID:33170686] [10.1021/acs.jmedchem.0c01084]
5. Seidah, Nabil G NG and 8 more authors.. (2003) The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.. Proceedings of the National Academy of Sciences of the United States of America, (4): [PMID:12552133]
6. Naureckiene, Saule S and 13 more authors.. (2003) Functional characterization of Narc 1, a novel proteinase related to proteinase K.. Archives of biochemistry and biophysics, (1): [PMID:14622975]
7. Kotowski, Ingrid K IK and 6 more authors.. (2006) A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.. American journal of human genetics, [PMID:16465619]
8. Benjannet, Suzanne S, Rhainds, David D, Hamelin, Josée J, Nassoury, Nasha N and Seidah, Nabil G NG.. (2006) The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications.. The Journal of biological chemistry, (13): [PMID:16912035]
9. Nassoury, Nasha N and 9 more authors.. (2007) The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.. Traffic (Copenhagen, Denmark), [PMID:17461796]
10. Piper, Derek E DE and 7 more authors.. (2007) The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol.. Structure (London, England : 1993), [PMID:17502100]
11. Ding, Keyue K, McDonough, Samantha J SJ and Kullo, Iftikhar J IJ.. (2007) Evidence for positive selection in the C-terminal domain of the cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14 primate species.. PloS one, (31): [PMID:17971861]
12. Poirier, Steve S and 9 more authors.. (2008) The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.. The Journal of biological chemistry, (25): [PMID:18039658]
13. Fan, Daping D and 6 more authors.. (2008) Self-association of human PCSK9 correlates with its LDLR-degrading activity.. Biochemistry, (12): [PMID:18197702]
14. and Lopez, Dayami D.. (2008) PCSK9: an enigmatic protease.. Biochimica et biophysica acta, [PMID:18280815]
15. Dewpura, Thilina T and 6 more authors.. (2008) PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans.. The FEBS journal, [PMID:18498363]
16. Lambert, Gilles G, Charlton, Francesca F, Rye, Kerry-Anne KA and Piper, Derek E DE.. (2009) Molecular basis of PCSK9 function.. Atherosclerosis, [PMID:18649882]
17. Jonas, Mary Cabell MC, Costantini, Claudio C and Puglielli, Luigi L.. (2008) PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1.. EMBO reports, [PMID:18660751]
18. Mayer, Gaétan G, Poirier, Steve S and Seidah, Nabil G NG.. (2008) Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels.. The Journal of biological chemistry, (14): [PMID:18799458]
19. Horton, Jay D JD, Cohen, Jonathan C JC and Hobbs, Helen H HH.. (2009) PCSK9: a convertase that coordinates LDL catabolism.. Journal of lipid research, [PMID:19020338]
20. Abifadel, Marianne M and 7 more authors.. (2009) Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.. Human mutation, [PMID:19191301]
21. Abifadel, Marianne M and 13 more authors.. (2009) The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.. Human mutation, [PMID:19319977]
22. Yamamoto, Taichi T, Lu, Christine C and Ryan, Robert O RO.. (2011) A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor.. The Journal of biological chemistry, (18): [PMID:21149300]
23. Du, Fen F and 5 more authors.. (2011) Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein.. The Journal of biological chemistry, (16): [PMID:22027821]
24. Chen, Yanqun Y and 6 more authors.. (2011) Role of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation.. Biochemical and biophysical research communications, (25): [PMID:22074827]
25. Huijgen, Roeland R and 7 more authors.. (2012) Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels.. Human mutation, [PMID:22095935]
26. Slimani, Afef A and 14 more authors.. (2012) Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.. Atherosclerosis, [PMID:22417841]
27. Sharotri, Vikas V, Collier, Daniel M DM, Olson, Diane R DR, Zhou, Ruifeng R and Snyder, Peter M PM.. (2012) Regulation of epithelial sodium channel trafficking by proprotein convertase subtilisin/kexin type 9 (PCSK9).. The Journal of biological chemistry, (1): [PMID:22493497]
28. Sun, Hua H and 5 more authors.. (2012) Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor.. Arteriosclerosis, thrombosis, and vascular biology, [PMID:22580899]
29. Zhang, Yingnan Y and 12 more authors.. (2014) Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor.. The Journal of biological chemistry, (10): [PMID:24225950]
30. Ly, Kévin K and 9 more authors.. (2014) Annexin A2 reduces PCSK9 protein levels via a translational mechanism and interacts with the M1 and M2 domains of PCSK9.. The Journal of biological chemistry, (20): [PMID:24808179]
31. Tagliabracci, Vincent S VS and 14 more authors.. (2015) A Single Kinase Generates the Majority of the Secreted Phosphoproteome.. Cell, (18): [PMID:26091039]
32. Devito, Fiorella F and 7 more authors.. (2015) Focus on alirocumab: A PCSK9 antibody to treat hypercholesterolemia.. Pharmacological research, [PMID:26455563]
33. Kosmas, Constantine E and 6 more authors.. (2018) Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia.. Diseases (Basel, Switzerland), (13): [PMID:30011788]

溶液计算器

摩尔浓度计算器

计算溶液所需的质量、体积或浓度。

质量

浓度

体积

分子量

g/mol

稀释计算器

计算配制储备溶液所需的稀释度。

浓度1（C1）

体积 1 (V1)

浓度 2 (C2)

体积 2 (V2)

复溶计算器

复溶计算器允许您快速计算试剂的体积，以复溶小瓶。只需输入试剂的质量和目标浓度，计算器将确定其余部分。

体积（添加到小瓶中）

质量（小瓶）

所需的复溶浓度

Bococizumab (anti-PCSK9), 9 型枯草蛋白酶/kexin 抗体

库存信息

库存信息

库存信息

库存信息

基本信息

产品属性

图片

关联靶点（人）

作用机制

安全和危险性（GHS）

技术规格说明书

质检证书（CoA,COO,BSE/TSE 和分析图谱)

可替换产品

参考文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器

Bococizumab (anti-PCSK9), 9 型枯草蛋白酶/kexin 抗体

库存信息

库存信息

库存信息

库存信息

基本信息

产品属性

图片

关联靶点（人）

作用机制

安全和危险性（GHS）

技术规格说明书

质检证书（CoA,COO,BSE/TSE 和分析图谱)

相关产品

可替换产品

参考文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器